Showing all 2 results
Neostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Neostigmine Bromide Ph.Eur./USP 15 mg Global Clinical Standard: Base therapeutic oral unit for the continuous, meticulously spaced symptomatic management of Myasthenia Gravis. Excipients Lactose Monohydrate / Maize Starch / Povidone K30 / Talc / Magnesium Stearate Diluent / Binder / Glidant / Lubricant (Engineered specifically for rapid, predictable gastric dissolution to ensure precise symptom control within 30 to 45 minutes of ingestion) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, high-volume chronic neurology dispensing, as patients may require up to 10-15 tablets per day in divided doses).
Pyridostigmine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-density HDPE bottles with desiccants to ensure the absolute chemical stability of the highly hygroscopic bromide salt.
Active Ingredient Strength Primary Clinical Function Pyridostigmine Bromide USP/Ph.Eur. 60 mg Global Clinical Standard: Base maintenance dose for continuous 24-hour neuromuscular control in MG patients. Excipients Silicone Dioxide / Microcrystalline Cellulose / Pregelatinized Starch / Magnesium Stearate Glidant / Diluent / Binder / Lubricant (Engineered for immediate gastric dissolution and precise, rapid systemic onset within 30-45 minutes) *Pack Sizes: Bottles of 100 or 10×10 Alu-Alu Blisters (Optimized specifically for strict, high-volume daily neurology regimens where patients may consume 6 to 10 tablets daily).
